Research recover from illness defense complex helper T cell immune mechanisms based on the Fuxie theory clearing away heat evil thoroughly nourishing kidney treatment of recurrent blood-heat syndrome Psoriasis
- Conditions
- Psoriasis vulgaris
- Registration Number
- ITMCTR1900002302
- Lead Sponsor
- Chengdu University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Patients inclusion criteria: 1.Complies with the diagnostic criteria for psoriasis vulgaris in dermatovenerology 8th Edition; 2. Complies with the diagnostic criteria for blood-heat syndrome in Guidelines for the Clinical Research of Chinese Medicine New Drugs and New Dermatology of Traditional Chinese Medicine; 3. Aged 18 to 70 years; 4. Patients signed informed consent; 5. Recurrent psoriasis patients must belong to the types of recurrenceIV, V, VI.
Health volunteers inclusion criteria: 1. Aged 18 to 65 years; 2. No family history of psoriasis; 3. People who used corticosteroids or immune agents within a month. 4. People without serious systemic diseases, tumors, immunodeficiency or mental disorders.
1. Psoriasis with other skin diseases; 2. Combined with cardiovascular and cerebrovascular diseases, liver, kidney and hematopoietic system diseases; other severe systemic chronic wasting diseases, and mental diseases; 3. Patients who have hyperlipidemia, vitamin A too high, women of childbearing age; 4. Received systemic glucocorticoid, retinoic acid and methotrexate drugs within a month, use glucocorticoid drugs in external for nearly 2 weeks.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection and screening of downstream cytokines(IFN-?\IL-4\IL-17A\IL-17F\IL-22\TGF-ß\IL-10 \IL- 9);Itching degree score;The quantities and distribution of Th1, Th2, Th17, Treg, Th22 and Th9 cells in peripheral blood;Genes and proteins levels of transcription factors(T-bet\GATA3\ROR?t\Foxp3);Psoriasis area and severity index;
- Secondary Outcome Measures
Name Time Method